Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00845052
Other study ID # 0807009889
Secondary ID
Status Completed
Phase N/A
First received February 13, 2009
Last updated February 2, 2017
Start date July 2008
Est. completion date September 2011

Study information

Verified date February 2017
Source Weill Medical College of Cornell University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: The occurrence of medical errors and their deleterious effects on quality of care delivered are widely recognized phenomena in healthcare today. This has spurned an aggressive nationwide campaign to improve the quality of care all hospitals throughout the country. Currently, there are numerous reports of quality improvement initiatives across medical centers in the United States. However, a review of the literature failed to identify any publications regarding targeted resident/housestaff involvement in hospital quality improvement and safety related activities.

Purpose: To investigate and track housestaff attitudes on patient care, patient safety, communication and overall quality within the institution.

Objective: To investigate, analyze and publish the results of this prospective study. The information obtained will help us and others understand whether proactive attempts to change housestaff culture can indeed change attitudes towards the better with regards to patient care and safety. It is assumed that improved attitudes ultimately translates into improved care and safety.

Methods: Each residency coordinator in each clinical department will be asked to distribute a survey, which has already been validated for this type of investigation, to each resident in the respective program (see attachment).

The Vice-President of Medical Affairs will provide a cover letter to help with the process. After a week, a reminder will be distributed by the coordinators to each resident asking them to fill out the survey. The surveys will be filled out anonymously. However, each participant will be asked to note their sex, department and year of postgraduate training. This process will be repeated every eight months until June of 2010. The Housestaff Quality council (HQC) has already distributed and collected this survey. The results of those surveys will be used in a retrospective part of this study. The results of (HQC) survey will be used to establish a baseline of the housestaff attitudes at the New York Presbyterian Hospital-Weill Cornell.

Data will be stored on a password protected computer. The Institutional Review Board (IRB), Office of Human Research Protection and Food and Drug Administration and all appropriate federal oversight agencies may have access to those files.


Description:

Each residency coordinator in each clinical department will be asked to distribute a survey, which has already been validated for this type of investigation, to each resident in the respective program


Recruitment information / eligibility

Status Completed
Enrollment 674
Est. completion date September 2011
Est. primary completion date June 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Members of housestaff working at New York Presbyterian Hospital - Weill Medical College of Cornell University Exclusion Criteria: Not meeting the inclusion criteria

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Weill Medical College of Cornell University New York New York

Sponsors (1)

Lead Sponsor Collaborator
Weill Medical College of Cornell University

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT04485481 - Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers Phase 1
Completed NCT03473236 - Phase 1A Safety Trial of Inhaled PK10571 (GB002) Phase 1
Not yet recruiting NCT03683953 - The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells Phase 1
Recruiting NCT05546567 - NOPARK Open Label Extension Study N/A
Recruiting NCT05413226 - Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility N/A
Recruiting NCT05112159 - Study of IPG1094 in Healthy Participants Phase 1
Completed NCT04689035 - A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144 Phase 1
Completed NCT04335045 - Phase I Study of PH100 (Ecklonia Cava Phlorotannins) Phase 1
Completed NCT05037227 - Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia
Recruiting NCT05517291 - DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease N/A
Enrolling by invitation NCT06446778 - Haemodynamic Mechanisms and Multicentre Prospective Cohort Study of the Pipeline Flow-diverting Device for the Treatment of Intracranial Aneurysms. Evaluation of the Safety and Efficacy of the Pipeline Flow-diverting Device for the Treatment of Intracranial Aneurysms
Recruiting NCT04573049 - The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement Phase 4
Completed NCT05585463 - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Completed NCT04188821 - Reduction of Seroma and Improvement of QoL in Breast Reconstruction With Tissue Expander N/A
Completed NCT03667430 - Safety Evaluation of Porous Silica in Men N/A
Completed NCT04499482 - Safety and Tolerability of Soy Fiber N/A
Completed NCT03141905 - Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease N/A
Completed NCT05244161 - A Quasi-experimental Evaluation of the Malezi Program in Tanzania N/A
Recruiting NCT03791372 - Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy Phase 1
Withdrawn NCT04759066 - The HEALiX™ Intubated Patient (IP) Pilot Study N/A